Whistleblower News From The Inside — December 17, 2015

By the C|C Whistleblower Lawyer Team

Qualitest Pharmaceuticals pays $39 million to federal government and 47 states to resolve 2013 whistleblower lawsuit over half-strength fluoride supplements — “A generic drug maker owned by Endo International Plc has reached a $39 million settlement with the U.S. government and 47 states stemming from the unlawful labeling of multivitamins that contained fluoride.” Reuters

United States intervenes in 3 whistleblower lawsuits against SavaSeniorCare for unnecessary rehab services —  “The federal government has jumped into three lawsuits alleging that skilled nursing chain SavaSeniorCare billed Medicare for medically unnecessary rehabilitation therapy services.”   ModernHealthcare

1st Circuit allows pharmacist whistleblower to revive his False Claims Act lawsuit against PharMerica Corp. — “A would-be whistleblower will get another chance to argue that pharmacy operator PharMerica Corp defrauded the government, even though he was not the first to make those allegations, a federal appeals court has held.”  Reuters

HHS offers federal funding to States to encourage them to data-mine for Medicaid fraud — “HHS says few states have taken it up on an offer to receive federal funding for data-mining, which would allow their Medicaid fraud units to search claims.” ModernHealthcare

A federal judge denies Bio-Rad Laboratories’ request for quick appeal of Whistleblower General Counsel’s retaliation claim —  “A California federal judge said Tuesday that Bio-Rad Laboratories can’t quickly appeal an unfavorable ruling in a whistleblower suit brought by its former general counsel who claims he was fired for raising potential bribery allegations, saying an appeal would unnecessarily prolong the case.”  Law360